A Clinical Study of Docetaxel for Injection (Albumin-bound) in Patients With Gastric Cancer
Clinical trial NCT06296706 · RECRUITING
Trial details
- NCT number
- NCT06296706
- Sponsor
- CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-02-27
- Primary completion
- 2026-06-01
- Enrollment
- 630
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.